SMMT
SMMT
NASDAQ · Biotechnology

Summit Therapeutics Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$14.19
-1.98 (-12.24%)
Analyst Consensus
Buy
24
Analysts
High
Coverage
Buy 17 71%
Hold 7 29%
Sell 0 0%
Price Target
Analyst Price Target +1,281.8% upside
Low Target $141.53
Average Target $196.08
High Target $244.39
Current Price $14.19
Current
$14.19
Target
$196.08
$141.53 $196.08 avg $244.39
Scenario Analysis
Bear Case
$141.53
897.4%
Low target
Base Case
$196.08
+1,281.8%
Avg target
Bull Case
$244.39
+1,622.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$29.23
-51.5% from high
52-Week Low
$12.07
+17.6% from low
50-Day SMA
$16.21
-12.5% vs SMA
200-Day SMA
$16.16
-12.2% vs SMA
RSI (14)
54.8
Neutral
Target vs 52W High
$196.08
+570.8% vs high
Next Earnings Report
Nov 11, 2026
4d
until earnings
EPS Est: $-0.29
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +115.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -42.4%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.4%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.8%